Literature DB >> 7481384

[Exacerbation of myasthenia gravis by pefloxacin].

T Vial1, G Chauplannaz, P Brunel, B Leriche, J C Evreux.   

Abstract

Pefloxacine 800 mg single dose was given as routine treatment after a cystomanometric examination to a 45-year-old woman with a 30-month history of generalized myasthenia gravis. One hour after, the patient developed exacerbation of myasthenia gravis with bilateral ptosis and an increased generalized weakness. She experienced a rapid improvement during the next 8 hours and physical examination returned to normal within one day. No additional factors which might have contributed to the exacerbation of myasthenia gravis were found. The report of exacerbation of myasthenia gravis with other antibiotic belonging to the group of fluoroquinolones (ciprofloxacin, norfloxacin and ofloxacin) prompt us to recommend caution with the use of all fluoroquinolones in myasthenic patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7481384

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  2 in total

1.  Investigation on the mechanism of exacerbation of myasthenia gravis by aminoglycoside antibiotics in mouse model.

Authors:  Changqin Liu; Fang Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

Review 2.  Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review.

Authors:  S Christopher Jones; Alfred Sorbello; Robert M Boucher
Journal:  Drug Saf       Date:  2011-10-01       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.